This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Analysts Estimate Celestica (CLS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Celestica (CLS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Celestica (CLS) Moves to Strong Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Celestica (CLS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Jabil (JBL) Catches Eye: Stock Jumps 7.8%
by Zacks Equity Research
Jabil (JBL) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.
Itron (ITRI) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Itron (ITRI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Celestica (CLS) Q2 Earnings Meet Estimates
by Zacks Equity Research
Celestica (CLS) delivered earnings and revenue surprises of 0.00% and -0.03%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Factors Setting the Tone for Celestica (CLS) in Q2 Earnings
by Zacks Equity Research
Celestica's (CLS) Q2 earnings are likely to benefit from synergies from Impakt and Atrenne buyouts; and solid adoption of JDM solutions. However, soft demand from OEM customers remains headwind.
Is Celestica (CLS) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Plexus (PLXS) Q3 Earnings Miss Estimates, Revenues Up Y/Y
by Zacks Equity Research
Plexus' (PLXS) third-quarter results benefit from robust revenues from Healthcare/Life Sciences and Aerospace/Defense sectors despite unfavorable mix, which hurt margins.
Earnings Preview: Celestica (CLS) Q2 Earnings Expected to Decline
by Zacks Equity Research
Celestica (CLS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should Value Investors Buy Celestica (CLS) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Do Options Traders Know Something About Celestica (CLS) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Celestica (CLS) stock based on the movements in the options market lately.
Earnings Preview: Celestica (CLS) Q1 Earnings Expected to Decline
by Zacks Equity Research
Celestica (CLS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What Do Fed Doves Foretell?
by John Blank
Doves say 0 hikes in 2019, and maybe 1 rate cut in 2020.
Rates Hikes or No Rate Hikes?
by John Blank
0 Hikes, 1 Hike or 2 Hikes in 2019?
Should Value Investors Buy Celestica (CLS) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Celestica (CLS) Misses Q4 Earnings Estimates
by Zacks Equity Research
Celestica (CLS) delivered earnings and revenue surprises of -6.45% and 0.67%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Industry Rank Highlights: Jabil and Celestica
by Zacks Equity Research
The Zacks Industry Rank Highlights: Jabil and Celestica
Follow Wearables to a Hot Industry Niche
by John Blank
Electronics Manufacturing Services (EMS) is at #11 out of 256 industries (in the top 4%) within the Zacks Industry Ranks.
Moving Average Crossover Alert: Celestica (CLS)
by Zacks Equity Research
Celestica Inc. (CLS) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
Celestica (CLS) Q3 Earnings Miss Estimates
by Zacks Equity Research
Celestica (CLS) delivered earnings and revenue surprises of -13.33% and 1.21%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Celestica (CLS) Q3 Earnings Preview: Here's What to Look Out For
by Zacks Equity Research
Celestica (CLS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should Value Investors Pick Celestica (CLS) Stock?
by Zacks Equity Research
Celestica (CLS) is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front.
Does Celestica Offer a Good Value Buying Opportunity Now?
by Zacks Equity Research
Let's put Celestica, Inc. (CLS) stock into this equation and find out if it is a good choice for value-oriented investors right now.